NCT01784211View on ClinicalTrials.gov

A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

LY2605541

DRUG

Insulin Glargine

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Neuss

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01784211 - A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes | Biotech Hunter | Biotech Hunter